Company: LNAI
Filing Date: 2025-09-29
Form Type: 10-K
Source: 0001731122-25-001316
Chunk: 187

Company: Lunai Bioworks Inc.
Filing Date: 2025-09-29
Form: 10-K
Item: Item 1B
Chunk 187
---
5; 158,452,644
    shares issued and outstanding at June 30, 2024 
     17,741  
     15,847 
  
    Additional
    paid-in capital 
     478,280,146  
     464,587,224 
  
    Accumulated
    deficit 
     (510,462,570) 
     (332,455,081)
  
    Accumulated
    other comprehensive (loss) 
     10,814,842  
     (170,846)
  
    Total
    Stockholders’ Equity (Deficit) 
     (21,349,841) 
     131,977,144 

    TOTAL
    LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT) 
    $8,230,840  
    $163,129,450 

The accompanying notes are an integral part of these
consolidated financial statements.

F-4

LUNAI BIOWORKS INC. FKA: RENOVARO INC. AND SUBSIDIARIES 

CONSOLIDATED STATEMENTS OF OPERATIONS

    For the Years Ended

    June 30,

    2025 
    2024

    Operating Expenses 

    General and administrative 
    $17,880,050  
    $24,557,608 
  
    Research and development 
     537,428  
     2,708,829 
  
    Intangible asset impairment 
     —  
     42,611,000 
  
    Goodwill impairment 
     170,419,429  
     11,640,000 
  
    Depreciation and amortization 
     129,095  
     121,859 
  
    Total Operating Expenses 
     188,966,002  
     81,639,296 
  
    LOSS FROM OPERATIONS 
     (188,966,002) 
     (81,639,296)

    Other Income (Expense) 

    Change in fair value of contingent consideration 
     11,680,000  
     (3,048,183)
  
    Loss on extinguishment of debt 
     —  
     (1,303,578)
  
    Change in fair value of equity securities 
     (112,149) 
     — 
  
    Interest expense